ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NRX Nurexone Biologic Inc

0.70
-0.03 (-4.11%)
26 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Nurexone Biologic Inc NRX TSX 벤처 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -4.11% 0.70 04:59:31
개장가 저가 고가 종가 전일 종가
0.68 0.68 0.71 0.70 0.73
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/06/202405:04GLOBEOn Path to First-in-Human Study, NurExone Engages Prominent..
11/06/202421:44GLOBENurExone Announces Expansion of ExoPTEN Patent Coverage with..
05/06/202405:40GLOBENurExone Announces Voting Results from 2024 Annual Meeting..
29/05/202421:35GLOBENurExone Reports First Quarter 2024 Financial Results and..
18/05/202405:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
26/04/202400:30APSShares of Biopharma Up After News of Uplisting
25/04/202421:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
20/04/202405:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/04/202421:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
28/03/202406:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
23/03/202406:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
16/03/202405:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
09/03/202406:05GLOBENurExone establishing State-of-the-Art Research and..
02/03/202406:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
21/02/202406:05GLOBENurExone’s Intellectual Property Portfolio Expands
15/02/202406:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
03/02/202406:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
17/01/202422:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
05/01/202422:30GLOBENurExone Announces Closing of a Private Placement for Gross..
29/11/202322:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
24/11/202322:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
17/11/202306:21APSTake Part in the Next Generation of Spinal Cord Injury..
08/11/202306:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
01/11/202306:00APSWhen Technicals and Fundamentals Converge, A Nice Uptrend..
31/10/202302:00APSShares Up Following Orphan Drug Designation
30/10/202322:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
26/10/202306:18APSMicrocap Offers Unique Opportunity for Investors In $10..
19/10/202321:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
19/10/202306:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
11/10/202323:00APSSmall Company Working on Big Breakthrough in Treating Spinal..
11/10/202321:30GLOBENurExone Secures Eureka Grant for Collaborative..
05/10/202321:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
28/09/202321:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
13/09/202321:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
06/09/202321:30GLOBENurExone Announces Closing of Second Tranche of Private..
09/08/202321:00GLOBENurExone Announces Private Placement
20/07/202321:15GLOBENurExone Biologic Announces Advancements in Extracellular..